Finance

Lists
200780:KOSDAQ
BCWorldPharm Co Ltd
â‚©3,020.00
-0.82%
(-25.00) 1D
Sep 4, 3:30:00 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 200780...
Open
â‚©3,045
High
â‚©3,045
Low
â‚©2,955
Mkt. cap
32.21B
Avg. vol.
11.23K
Volume
7.73K
Dividend
3.01%
Quarterly dividend
â‚©23
Ex-dividend date
Dec 29, 2025
52-wk high
â‚©6,030
52-wk low
â‚©2,795
EPS
-â‚©338
Shares outstanding
10.67M
No. of employees
280
Open
â‚©3,045
High
â‚©3,045
Low
â‚©2,955
Mkt. cap
32.21B
Avg. vol.
11.23K
Volume
7.73K
Dividend
3.01%
Quarterly dividend
â‚©23
Ex-dividend date
Dec 29, 2025
52-wk high
â‚©6,030
52-wk low
â‚©2,795
EPS
-â‚©338
Shares outstanding
10.67M
No. of employees
280
About BCWorldPharm Co Ltd
CEOHong Sung Han
Employees280
Founded1980
Headquarters-
SectorPharmaceutical industry
Websitebcwp.co.kr
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
19.25B
20.28B
19.83B
20.96B
Cost of goods sold
12.14B
12.23B
11.84B
13.63B
Cost of revenue
12.14B
12.23B
11.84B
13.63B
Research and development expenses
2.42B
2.21B
2.01B
2.75B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.12B
4.77B
3.87B
4.19B
Operating expense
6.96B
7.34B
6.18B
7.18B
Total operating expenses
19.10B
19.56B
18.03B
20.81B
Operating income
147.54M
719.12M
1.81B
147.30M
Other non operating income
93.01M
654.86M
80.68M
-335.87M
EBT including unusual items
-834.62M
346.56M
939.45M
-1.23B
EBT excluding unusual items
-743.67M
372.30M
959.26M
-1.21B
Income tax expense
146.11M
415.72M
153.81M
-229.12M
Effective tax rate
-17.51%
119.96%
16.37%
18.64%
Other operating expenses
80.59M
93.16M
77.63M
76.76M
Net income
-1.11B
-983.61M
332.94M
-1.13B
Net profit margin
-5.78%
-4.85%
1.68%
-5.41%
Earnings per share
-
-
-
-
Interest and investment income
49.94M
19.53M
15.90M
12.23M
Interest expense
-994.96M
-1.10B
-995.05M
-1.06B
Net interest expenses
-945.02M
-1.08B
-979.15M
-1.04B
Depreciation and amortization charges
132.65M
137.56M
142.11M
143.11M
EBITDA
2.13B
2.76B
3.88B
2.25B
Gain or loss from assets sale
1.00K
2.61M
41.53K
6.00M
AI content may include mistakes. Learn more
Google apps